Research institute in
Monthey

BioArk SA

Since 2003 · 11–20 empl.·4.3(21)

BioArk SA operates technology parks for companies and start-ups in biotechnology and diagnostics. It provides laboratory, cleanroom and office space and helps businesses find partners, expertise and support for business development.

Excellgene SA

Since 2004 · 11–20 empl.·5.0(1)

ExcellGene is a Swiss Biologics-CDMO (Contract Development and Manufacturing Organization) specialized in the development and manufacturing of proteins for the pharmaceutical industry. The company's core activity encompasses providing services for the development and manufacturing of biologics, including: cell line development (CHO and HEK cells), genome engineering, cGMP cell banking, process development, ensuring clonality of existing cell lines, and biosimilars. The company supports pharmaceutical companies in the development and manufacturing of proteins for drug development, offering a combination of scientific expertise and technological infrastructure.

Bionactis International Group (BIG) SA

Since 2009 · 1–10 empl.

Bionactis International Group (BIG) SA specializes in industrial adiabatic processes that replace organic solvents and reduce the energy required for chemical processes.

Patrice Ciana, Ciana.ch

Since 2015 · 1–10 empl.

Patrice Ciana, Ciana.ch provides business consulting, research and development, product development, and continuing education through tailored courses. Its work includes supporting digital transformations based on data analysis.

Karmagenes SA

Since 2015 · 1–10 empl.

Karmagenes SA develops psychometric and genetic analysis tools for organizations. Its services include personality and behavioral assessments for adults and children, combining psychological testing with genetic data to examine aspects of personality and behavior.

Swiss Biotech Center SA

Since 2016 · 11–20 empl.

Swiss Biotech Center SA develops and manufactures biopharmaceutical products, from research and development through clinical development. Its services include producing clinical batches of biologics to cGMP standards and supporting start-ups and project teams.

REM Analytics SA

Since 2020 · 1–10 empl.

The core activity of BioArk SA is the performance of microbiome analyses and food analyses, particularly in the examination of probiotics and their impact on the microbiome. The company offers services such as engraftment tests, quantitative effect analyses and durability analyses to determine the effectiveness of probiotics. Furthermore, BioArk SA provides food analyses, including the identification of origin, variety and pathogens in food. The company aims to support businesses in the development, improvement and certification of products.

Novochizol SA

Since 2021 · 1–10 empl.

Novochizol SA develops and researches applications for Novochizol™, a technology for producing biocompatible chitosan nanoparticles. These nanoparticles are used as delivery systems for active ingredients in pharmaceutical formulations and agricultural applications.

Catexel Production Switzerland GmbH

Since 2025 · 21–50 empl.

Catexel Production Switzerland GmbH operates in specialty chemicals and offers ingredients including bleach activators and catalysts, surfactants, hydrotropes and emulsifiers. Its products serve applications in home and personal care, industrial and institutional cleaning, and other industrial markets.

Swissaustral Biotech SA

Since 2009 · 1–10 empl.

Target Advisory Sàrl

Since 2024 · 1–10 empl.

Earthshot Labswork SA

Since 2025 · 1–10 empl.